Operating
Cardinal Health·Cash Flow Statement·13 metrics
Breakdown
| Metric | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|
| Net cash from operating activities | $2.1B | -$1.6B | -$396M | $2.9B | $1.5B | $973M | $686M | $1.8B |
| Net income | $233M | $417M | $401M | $508M | $243M | $454M | $471M | $380M |
| Depreciation and amortization | $186M | $182M | $192M | $207M | $209M | $233M | $234M | $248M |
| Gain (Loss) on Sale of Assets and Asset Impairment Charges | -$8M | $1M | -$3M | $17M | -$33M | -$2M | $14M | -$185M |
| Stock-based compensation | $33M | $30M | $30M | $31M | $153M | $93M | $87M | $129M |
| Other working capital changes | — | $508M | $129M | — | $79M | $699M | — | $63M |
| Accounts Receivable, Credit Loss Expense (Reversal) | $8M | $16M | $12M | $13M | $12M | $13M | $14M | $20M |
| Change in receivables | $773M | -$288M | $541M | $114M | $466M | $539M | — | $17M |
| Impairments and loss on sale of other investments | -$2M | — | — | — | -$1M | — | — | -$15M |
| Repurchases of liability-classified units | — | — | — | $0 | — | — | — | $5M |
| Change in accounts payable | — | -$1.4B | $924M | $1.4B | $1.8B | $2.1B | $2B | — |
| Change in inventories | -$2.4B | $678M | $1.3B | — | $607M | $736M | $2.5B | — |
| Deferred income taxes | -$26M | $60.8M | $60.8M | $60.8M | $60.8M | — | — | — |